Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
SAYER KEVIN R | President, CEO and Chairman | Feb 11 | Sale | 148.90 | 6,000 | 893,400 | 308,837 | Feb 13 07:23 PM | Murphy Patrick Michael | SVP Legal Affairs | Feb 08 | Sale | 142.76 | 400 | 57,104 | 29,308 | Feb 12 09:24 PM | Murphy Patrick Michael | SVP Legal Affairs | Feb 08 | Sale | 142.76 | 400 | 57,104 | 29,308 | Feb 12 04:46 PM | Pacelli Steven Robert | EVP, Strategy & Corp. Dev. | Jan 23 | Sale | 149.74 | 3,114 | 466,303 | 101,404 | Jan 24 05:46 PM | SAYER KEVIN R | President, CEO & Chairman | Jan 14 | Sale | 140.99 | 6,000 | 845,930 | 314,837 | Jan 15 05:30 PM | KAHN BARBARA | Director | Jan 14 | Sale | 142.30 | 10,631 | 1,512,827 | 16,817 | Jan 16 06:08 PM | Murphy Patrick Michael | SVP, GC & Chief Compliance Off | Jan 10 | Sale | 138.75 | 400 | 55,500 | 29,708 | Jan 14 09:42 PM | SKYLER JAY S | Director | Jan 02 | Option Exercise | 4.58 | 25,806 | 118,191 | 52,616 | Jan 04 05:03 PM | ALTMAN STEVEN R | Director | Jan 02 | Sale | 117.04 | 2,500 | 292,593 | 52,855 | Jan 04 05:03 PM | DOUBLEDAY RICHARD | EVP, Chief Commercial Officer | Dec 21 | Sale | 109.34 | 1,510 | 165,101 | 14,112 | Dec 26 08:33 PM | Pacelli Steven Robert | EVP, Strategy & Corp. Dev. | Dec 21 | Sale | 109.41 | 3,114 | 340,700 | 104,518 | Dec 26 08:22 PM | Balo Andrew K | EVP, Reg. Strategy, Clinical | Dec 14 | Sale | 121.23 | 5,000 | 606,167 | 73,105 | Dec 18 06:34 PM | SAYER KEVIN R | President, CEO & Chairman | Dec 10 | Option Exercise | 4.58 | 11,162 | 51,122 | 331,999 | Dec 12 09:08 PM | Murphy Patrick Michael | SVP, GC & Chief Compliance Off | Dec 10 | Sale | 121.90 | 400 | 48,760 | 30,108 | Dec 12 09:09 PM | SAYER KEVIN R | President, CEO & Chairman | Dec 10 | Sale | 121.67 | 11,162 | 1,358,041 | 320,837 | Dec 12 09:08 PM | DOUBLEDAY RICHARD | EVP, Chief Commercial Officer | Nov 23 | Sale | 121.35 | 1,736 | 210,664 | 15,622 | Nov 27 06:27 PM | Pacelli Steven Robert | EVP, Strategy & Corp. Dev. | Nov 23 | Sale | 121.42 | 3,114 | 378,105 | 107,632 | Nov 27 06:27 PM | Balo Andrew K | EVP, Reg. Strategy, Clinical | Nov 14 | Sale | 143.13 | 5,000 | 715,664 | 78,105 | Nov 16 05:14 PM | SAYER KEVIN R | President, CEO & Chairman | Nov 12 | Option Exercise | 4.58 | 11,161 | 51,117 | 331,998 | Nov 14 07:29 PM | SAYER KEVIN R | President, CEO & Chairman | Nov 12 | Sale | 146.43 | 11,161 | 1,634,284 | 320,837 | Nov 14 07:29 PM | Murphy Patrick Michael | SVP, GC & Chief Compliance Off | Nov 09 | Sale | 148.11 | 400 | 59,244 | 30,508 | Nov 13 08:14 PM | Abbey Donald | EVP, Quality & Regulatory Afrs | Nov 09 | Sale | 149.30 | 10,550 | 1,575,159 | 88,089 | Nov 13 08:13 PM | ACE HEATHER S | SVP Human Resources | Nov 09 | Sale | 147.32 | 4,258 | 627,294 | 65,081 | Nov 13 08:14 PM | Pacelli Steven Robert | EVP, Strategy & Corp. Dev. | Oct 23 | Sale | 128.85 | 3,114 | 401,253 | 110,746 | Oct 25 08:58 PM | DOUBLEDAY RICHARD | EVP, Chief Commercial Officer | Oct 23 | Sale | 128.72 | 1,736 | 223,466 | 17,358 | Oct 25 08:59 PM | Balo Andrew K | EVP, Reg. Strategy, Clinical | Oct 12 | Sale | 124.79 | 5,000 | 623,934 | 83,105 | Oct 16 05:27 PM | Murphy Patrick Michael | SVP, GC & Chief Compliance Off | Oct 10 | Sale | 122.20 | 400 | 48,880 | 30,908 | Oct 12 04:11 PM | SAYER KEVIN R | President, CEO & Chairman | Oct 08 | Option Exercise | 4.58 | 11,161 | 51,117 | 331,998 | Oct 10 07:48 PM | SAYER KEVIN R | President, CEO & Chairman | Oct 08 | Sale | 124.76 | 11,161 | 1,392,433 | 320,837 | Oct 10 07:48 PM | ALTMAN STEVEN R | Director | Oct 01 | Sale | 135.65 | 2,500 | 339,134 | 55,355 | Oct 03 04:50 PM | Leach Jacob Steven | Chief Technology Officer | Sep 28 | Sale | 143.95 | 47,600 | 6,852,139 | 0 | Oct 01 07:10 PM | DOUBLEDAY RICHARD | EVP, Chief Commercial Officer | Sep 24 | Sale | 141.20 | 1,736 | 245,129 | 19,094 | Sep 26 08:32 PM | Pacelli Steven Robert | EVP, Strategy & Corp. Dev. | Sep 24 | Sale | 141.25 | 3,114 | 439,841 | 113,860 | Sep 26 08:32 PM | Balo Andrew K | EVP, Reg. Strategy, Clinical | Sep 14 | Sale | 145.17 | 5,000 | 725,851 | 88,105 | Sep 18 07:54 PM | Leach Jacob Steven | SVP, Research & Development | Sep 12 | Option Exercise | 5.92 | 15,000 | 88,800 | 109,284 | Sep 14 04:35 PM | Blackford Quentin S. | EVP, CFO, PFO & PAO | Sep 11 | Sale | 147.04 | 8,440 | 1,241,028 | 87,131 | Sep 13 09:48 PM | SAYER KEVIN R | President, CEO & Chairman | Sep 10 | Option Exercise | 4.58 | 11,161 | 51,117 | 346,332 | Sep 12 09:17 PM | DOUBLEDAY RICHARD | EVP, Chief Commercial Officer | Sep 10 | Sale | 143.76 | 5,483 | 788,210 | 66,804 | Sep 12 09:22 PM | MOY JEFFREY | SVP, Operations | Sep 10 | Sale | 143.35 | 5,736 | 822,256 | 16,711 | Sep 12 09:22 PM | MOY JEFFREY | SVP, Operations | Sep 10 | Sale | 143.76 | 4,594 | 660,411 | 63,920 | Sep 12 09:22 PM | Murphy Patrick Michael | VP, Legal Aff & Chf Compl Ofcr | Sep 10 | Sale | 143.69 | 2,372 | 340,825 | 31,308 | Sep 12 09:20 PM | Pacelli Steven Robert | EVP, Strategy & Corp. Dev. | Sep 10 | Sale | 143.76 | 5,483 | 788,210 | 116,974 | Sep 12 09:21 PM | Balo Andrew K | EVP, Reg. Strategy, Clinical | Sep 10 | Sale | 143.76 | 5,587 | 803,160 | 93,105 | Sep 12 09:21 PM | ACE HEATHER S | SVP Human Resources | Sep 10 | Sale | 143.76 | 1,832 | 263,360 | 69,339 | Sep 12 09:19 PM | Leach Jacob Steven | SVP, Research & Development | Sep 10 | Sale | 143.76 | 4,614 | 663,286 | 94,284 | Sep 12 09:20 PM | Abbey Donald | EVP, Quality & Regulatory Afrs | Sep 10 | Sale | 143.76 | 2,303 | 331,068 | 98,639 | Sep 12 09:19 PM | Blackford Quentin S. | EVP, CFO, PFO & PAO | Sep 10 | Sale | 143.76 | 7,149 | 1,027,706 | 95,571 | Sep 12 09:18 PM | SAYER KEVIN R | President, CEO & Chairman | Sep 10 | Sale | 143.62 | 25,495 | 3,661,573 | 320,837 | Sep 12 09:17 PM | Leach Jacob Steven | SVP, Research & Development | Aug 24 | Option Exercise | 4.52 | 20,577 | 92,941 | 109,455 | Aug 28 06:58 PM | ALTMAN STEVEN R | Director | Aug 24 | Sale | 136.47 | 5,000 | 682,359 | 0 | Aug 28 08:32 PM | FOLETTA MARK G | Director | Aug 24 | Sale | 137.50 | 1,000 | 137,503 | 17,095 | Aug 28 07:01 PM | Leach Jacob Steven | SVP, Research & Development | Aug 24 | Sale | 138.32 | 20,577 | 2,846,155 | 98,878 | Aug 28 06:58 PM | Pacelli Steven Robert | EVP, Strategy & Corp. Dev. | Aug 23 | Sale | 139.96 | 3,114 | 435,843 | 122,457 | Aug 27 05:20 PM | DOUBLEDAY RICHARD | EVP, Chief Commercial Officer | Aug 23 | Sale | 140.03 | 2,584 | 361,833 | 0 | Aug 27 05:20 PM | Balo Andrew K | EVP, Reg. Strategy, Clinical | Aug 14 | Sale | 124.25 | 5,000 | 621,253 | 98,567 | Aug 16 06:08 PM | SAYER KEVIN R | President, CEO & Chairman | Aug 13 | Option Exercise | 4.58 | 11,161 | 51,117 | 346,332 | Aug 15 05:15 PM | SAYER KEVIN R | President, CEO & Chairman | Aug 13 | Sale | 123.22 | 11,161 | 1,375,211 | 335,171 | Aug 15 05:15 PM | Murphy Patrick Michael | VP, Legal Aff & Chf Compl Ofcr | Aug 10 | Sale | 124.18 | 12,500 | 1,552,310 | 33,680 | Aug 14 08:32 PM | AUGUSTINOS NICHOLAS | Director | Aug 06 | Sale | 121.77 | 3,230 | 393,301 | 14,362 | Aug 08 08:33 PM | AUGUSTINOS NICHOLAS | Director | Aug 06 | Sale | 121.18 | 9,070 | 1,099,080 | 7,802 | Aug 08 08:33 PM | MOY JEFFREY | SVP, Operations | Aug 01 | Sale | 94.13 | 5,831 | 548,872 | 5,061 | Aug 03 04:50 PM | Pacelli Steven Robert | EVP, Strategy & Corp. Dev. | Jul 25 | Sale | 101.91 | 3,114 | 317,335 | 125,571 | Jul 27 05:09 PM | DOUBLEDAY RICHARD | EVP, Chief Commercial Officer | Jul 23 | Sale | 102.48 | 2,581 | 264,513 | 1,067 | Jul 25 07:54 PM | GREGG TERRANCE H | Executive Chairman | Jul 16 | Sale | 99.56 | 10,000 | 995,561 | 50,882 | Jul 18 05:50 PM | Balo Andrew K | EVP, Reg. Strategy, Clinical | Jul 16 | Sale | 99.56 | 5,000 | 497,816 | 103,567 | Jul 18 05:50 PM | SAYER KEVIN R | President & CEO | Jul 09 | Sale | 99.79 | 14,219 | 1,418,856 | 335,171 | Jul 11 09:07 PM | MOY JEFFREY | SVP, Operations | Jun 28 | Sale | 92.48 | 59,193 | 5,474,297 | 10,892 | Jul 02 08:51 PM | DOUBLEDAY RICHARD | EVP, Chief Commercial Officer | Jun 25 | Sale | 98.58 | 2,581 | 254,431 | 3,648 | Jun 26 08:26 PM | GREGG TERRANCE H | Executive Chairman | Jun 15 | Sale | 97.81 | 10,000 | 978,096 | 882 | Jun 19 08:37 PM | TOPOL ERIC | Director | Jun 12 | Sale | 100.10 | 20,000 | 2,001,998 | 84,562 | Jun 13 08:19 PM | DOUBLEDAY RICHARD | EVP, Chief Commercial Officer | May 23 | Sale | 86.00 | 2,581 | 221,963 | 6,229 | May 25 07:52 PM | GREGG TERRANCE H | Executive Chairman | May 15 | Sale | 85.90 | 10,000 | 858,974 | 882 | May 17 06:49 PM | SKYLER JAY S | Director | May 14 | Option Exercise | 4.58 | 30,000 | 137,400 | 52,257 | May 16 08:00 PM | SKYLER JAY S | Director | May 14 | Sale | 88.00 | 30,000 | 2,640,000 | 22,257 | May 16 08:00 PM | Pacelli Steven Robert | EVP, Strategy & Corp. Dev. | May 10 | Option Exercise | 7.63 | 2,855 | 21,784 | 128,685 | May 11 08:03 PM | SAYER KEVIN R | President & CEO | May 09 | Option Exercise | 7.63 | 31,464 | 240,070 | 366,635 | May 10 07:54 PM | Leach Jacob Steven | SVP, Research & Development | May 09 | Option Exercise | 9.72 | 8,745 | 85,017 | 107,420 | May 10 07:54 PM | Leach Jacob Steven | SVP, Research & Development | May 09 | Sale | 84.77 | 8,745 | 741,328 | 98,878 | May 10 07:54 PM | SAYER KEVIN R | President & CEO | May 09 | Sale | 84.37 | 17,245 | 1,454,992 | 349,390 | May 10 07:54 PM | SKYLER JAY S | Director | May 08 | Option Exercise | 7.63 | 31,464 | 240,070 | 53,721 | May 09 08:22 PM | Leach Jacob Steven | SVP, Research & Development | May 08 | Option Exercise | 3.19 | 1,923 | 6,134 | 100,801 | May 10 07:54 PM | Leach Jacob Steven | SVP, Research & Development | May 08 | Sale | 85.15 | 2,500 | 212,874 | 47,600 | May 10 07:54 PM | Leach Jacob Steven | SVP, Research & Development | May 08 | Sale | 84.95 | 1,923 | 163,366 | 98,878 | May 10 07:54 PM | SKYLER JAY S | Director | May 08 | Sale | 85.11 | 31,464 | 2,678,024 | 22,257 | May 09 08:22 PM | DOUBLEDAY RICHARD | EVP, Chief Commercial Officer | Apr 23 | Sale | 73.09 | 2,581 | 188,649 | 8,810 | Apr 25 07:33 PM | GREGG TERRANCE H | Executive Chairman | Apr 16 | Sale | 73.04 | 10,000 | 730,414 | 882 | Apr 18 07:24 PM | DOUBLEDAY RICHARD | EVP, Chief Commercial Officer | Mar 23 | Sale | 68.44 | 2,581 | 176,643 | 11,391 | Mar 27 06:54 PM | GREGG TERRANCE H | Executive Chairman | Mar 15 | Sale | 65.51 | 10,000 | 655,122 | 10,882 | Mar 19 08:08 PM | DOUBLEDAY RICHARD | EVP, Chief Commercial Officer | Feb 23 | Sale | 56.32 | 1,638 | 92,252 | 13,972 | Feb 27 05:32 PM |
|